Dividend policy


The Board has adopted a progressive dividend policy, intending to maintain or grow the dividend each year but, recognising that some earnings fluctuations are to be expected, the annual dividend will reflect the Board’s view of the earnings prospects over the entirety of the investment cycle.

In setting the distribution policy and the overall financial strategy, the Board’s aim is to continue to strike a balance between the interests of the business, our financial creditors and our shareholders. After providing for business investment, funding the progressive dividend policy and meeting our debt service obligations, the Board will keep under review the opportunity to return cash in excess of these requirements to shareholders through periodic share repurchases.

Announcement & payment of dividends

Dividends will normally be paid twice a year, with a greater proportion paid as a second interim.

  • First interim: announced with second quarter and half year results and paid in September
  • Second interim: announced with fourth quarter and full year results and paid in March

Dividend calculator & history

To calculate the value of your forthcoming/latest dividend payment, or to look-up previous payments, please use the dividend calculator.

Exchange rates

Exchange rates used to convert dividend payments, announced in USD, GBP and SEK are the noon rate on the day prior to the dividend announcement.

Dividend questions

Please refer to the dividend FAQ for common questions regarding dividend payments.

Most recent dividend announcement

The first interim dividend 2017 announced on Thursday 27 July 2017.

 

Dividend dates

 

 

Ex dividend date (Ordinary Shares)

 

10 August 2017

Ex dividend date (American Depositary Shares)

 

9 August 2017

Record date

 

11 August 2017

Payment date

 

11 September 2017

     

Dividend rates

 

 

GBP

 

0.689

USD

 

0.90*

SEK

 

0.0740


*For holders of American Depositary Shares (ADSs) this equates to $0.45 per ADS.
Following the ratio change to the Company’s NYSE-listed sponsored Level 2 American Depositary Receipt programme on 27 July 2015, two ADSs equal one Ordinary Share.

 

  • Annual Reports

    Our Annual Report provides a wide range of information about our global business.


  • Our Pipeline

    Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development


  • Shareholder FAQs

    Answers to frequently asked shareholder questions.